Literature DB >> 22809198

Isostructural series of nine-coordinate chiral lanthanide complexes based on triazacyclononane.

James W Walton1, Rachel Carr, Nicholas H Evans, Alexander M Funk, Alan M Kenwright, David Parker, Dmitry S Yufit, Mauro Botta, Sara De Pinto, Ka-Leung Wong.   

Abstract

Nonadentate ligands based on triazacyclononane incorporating pyridyl-2-phosphinate groups form an isostructural series of complexes with Ln ions in the solid state and in solution. The Ln ion is effectively shielded from the solvent environment. Crystal structures reveal a rigid C(3)-symmetric tricapped trigonal-prismatic coordination geometry that is maintained in solution for the methyl and phenylphosphinate series, as shown by multinuclear NMR analysis. Variable-temperature measurements of the field dependence of the water proton relaxivity in gadolinium complexes indicate that these systems exclude solvent from the primary coordination environment and minimize the second sphere of solvation. The electronic relaxation time for the gadolinium methylphosphinate complex has been estimated to be 550 (±150) ps by EPR and NMR methods, compared to values of around 0.30-0.05 ps for the terbium-ytterbium series, deduced by analyzing the field dependence (4.7-16.5 T) of the (31)P NMR longitudinal relaxation times. Values are compared with analogous azacarboxylate ligand complexes, supporting a key role for donor atom polarizability in determining the electronic relaxation. Spectral emission behavior in solution of samarium, europium, terbium, and dysprosium complexes is compared, and the resolved RRR-Λ and SSS-Δ complexes show strong circularly polarized luminescence. The molecular quadratic hyperpolarizability 〈β(HLS)〉 has been measured in solution using hyper-Raleigh light-scattering methods, for the whole series of lanthanide complexes of one ligand. The values of 〈β(HLS)〉 reach a maximum around the center of the series and are not simply dependent on the number of f electrons, suggesting a dominant contribution from the octupolar rather than the dipolar term.

Entities:  

Year:  2012        PMID: 22809198     DOI: 10.1021/ic300147p

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  6 in total

1.  Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents.

Authors:  Eszter Boros; Shima Karimi; Nathaniel Kenton; Lothar Helm; Peter Caravan
Journal:  Inorg Chem       Date:  2014-06-12       Impact factor: 5.165

2.  Critical analysis of the limitations of Bleaney's theory of magnetic anisotropy in paramagnetic lanthanide coordination complexes.

Authors:  Alexander M Funk; Katie-Louise N A Finney; Peter Harvey; Alan M Kenwright; Emily R Neil; Nicola J Rogers; P Kanthi Senanayake; David Parker
Journal:  Chem Sci       Date:  2014-12-17       Impact factor: 9.825

3.  Circularly polarised luminescence (CPL) control of oligopeptide-Eu(iii) hybridized luminophores by interaction with peptide side chains.

Authors:  Yuki Mimura; Takuya Sato; Yuki Motomura; Hiroki Yoshikawa; Motohiro Shizuma; Mizuki Kitamatsu; Yoshitane Imai
Journal:  RSC Adv       Date:  2020-01-14       Impact factor: 3.361

4.  A High-Throughput Method To Measure Relative Quantum Yield of Lanthanide Complexes for Bioimaging.

Authors:  Alexia G Cosby; Gregory Quevedo; Eszter Boros
Journal:  Inorg Chem       Date:  2019-08-05       Impact factor: 5.436

5.  Chelation with a twist: a bifunctional chelator to enable room temperature radiolabeling and targeted PET imaging with scandium-44.

Authors:  Brett A Vaughn; Shin Hye Ahn; Eduardo Aluicio-Sarduy; Justin Devaraj; Aeli P Olson; Jonathan Engle; Eszter Boros
Journal:  Chem Sci       Date:  2019-11-20       Impact factor: 9.825

6.  Synthesis and Evaluation of Europium Complexes that Switch on Luminescence in Lysosomes of Living Cells.

Authors:  Matthieu Starck; Jack D Fradgley; Robert Pal; Jurriaan M Zwier; Laurent Lamarque; David Parker
Journal:  Chemistry       Date:  2020-12-15       Impact factor: 5.020

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.